TAMTERO 20MG TABLET

About

Tamtero 20mg Tablet is a selective estrogen receptor modulator (SERM) widely used in the treatment and prevention of estrogen receptor-positive (ER+) breast cancer. It acts as an anti-estrogen in breast tissue by competitively binding to estrogen receptors, thereby blocking the growth-promoting effects of estrogen on cancer cells. In other tissues, such as bone and uterus, it may exhibit estrogenic effects. This dual action makes it a valuable therapeutic agent for both pre- and post-menopausal women with ER+ breast cancer, helping to reduce recurrence and improve survival outcomes. It is taken orally, offering convenience for long-term therapy.

Uses

• Adjuvant treatment of ER+ breast cancer
• Treatment of metastatic ER+ breast cancer
• Reduction in incidence of invasive breast cancer in high-risk women
• Reduction in incidence of contralateral breast cancer

Directions For Use

Taken orally, usually once or twice daily, with or without food, as directed by a physician.

Benefits

• Reduces breast cancer recurrence risk
• Improves survival in ER+ breast cancer patients
• Prevents new primary breast cancer development
• Effective in both pre- and post-menopausal women
• Well-established long-term safety profile
• Convenient oral administration

Side Effects

• Hot flashes
• Vaginal discharge or bleeding
• Nausea
• Fatigue
• Fluid retention (edema)
• Mood changes or depression
• Endometrial changes (hyperplasia, polyps, cancer)
• Thromboembolic events (blood clots like DVT, PE)
• Cataracts or vision changes
• Skin rash
• Headache
• Uterine fibroids

Safety Measures

• Alcohol - Moderate alcohol consumption is generally acceptable, but excessive intake may increase the risk of liver side effects.
• Pregnancy - Contraindicated. Can cause fetal harm. Effective non-hormonal contraception is required during treatment and for two months after.
• Breastfeeding - Not recommended. Tamoxifen and its metabolites may be excreted in breast milk and could cause serious adverse effects in the infant.
• Liver - Use with caution in patients with pre-existing liver disease. Monitor liver function tests regularly, as tamoxifen is metabolized by the liver.
• Kidney - No specific dose adjustment required for renal impairment, but caution is advised in severe renal dysfunction.
• Lung - No specific lung-related safety concerns, but monitor for signs of pulmonary embolism (e.g., sudden shortness of breath, chest pain) due to increased risk of blood clots.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.